Bacteremia
📧 Sign up to get email alerts when something new happens for Bacteremia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-04-05FDA Approved: NAFCILLIN — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application for Nafcillin submitted by Baxter Healthcare Corporation under NDA 050655.
-
FDA approval · 2018-02-21FDA Approved: VANCOMYCIN HYDROCHLORIDE — Supplemental Application (SAMSON MEDICAL TECHNOLOGIES LLC)
The FDA approved Samson Medical Technologies LLC's supplemental application for vancomycin hydrochloride, a generic antibiotic, under an app…
-
CLINICAL_TRIALS trial_result · 2018-02-01Clinical Trial Update: IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB [Phase 4]
Phase 4 clinical trial update on an IL-10 stratifying tool intended to guide antibiotic selection for MRSA bacteremia has completed.
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection [Phase 2]
Phase 2 trial update exploring a treatment algorithm to reduce vancomycin use in adults with bacteremia.
-
CLINICAL_TRIALS trial_result · 2017-11-27Clinical Trial Update: Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy [Phase 2]
Phase 2 study evaluating whether amoxicillin given around intensive periodontal therapy reduces bacteremia and inflammatory biomarkers.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-01Clinical Trial Update: Ecological Effects of Decolonisation Strategies in Intensive Care [Phase 3]
Phase 3 clinical trial assessing the ecological impact of decolonisation strategies in intensive care on multidrug-resistant bacteria and IC…
-
FDA approval · 2017-09-12FDA Approved: DAPTOMYCIN — Original Application (Sagent Pharmaceuticals)
FDA approval record for Daptomycin under an Original Application by Sagent Pharmaceuticals (NDA 208385). The entry documents FDA approval of…
-
FDA approval · 2017-07-14FDA Approved: NAFCILLIN — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for naficillin submitted by Baxter Healthcare Corporation.
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus [Phase 3]
Phase 3 trial evaluating daptomycin for infective endocarditis or bacteremia due to Staphylococcus aureus has completed.
-
CLINICAL_TRIALS research · 2017-01-13Clinical Trial Update: Prospective Study to Characterize Host-pathogen Related Factors in Hospitalized and ED Patients With LRTI and/or Sepsis
A prospective observational study by MeMed Diagnostics completed to characterize host-pathogen factors in hospitalized and ED patients with …
-
FDA label_change · 2016-12-21FDA Approved: DAPTOMYCIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved the supplemental application for daptomycin by Hikma Pharmaceuticals USA Inc., resulting in changes to the labeling and potenti…
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Prevalence of CVC-associated Sepsis and Use of Blood Cultures in Berlin - Brandenburg
The Berlin-Brandenburg clinical trial on the prevalence of central venous catheter–associated sepsis and use of blood cultures was terminate…
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Population Pharmacokinetic (PK) Study of Multiple Doses of Cubicin® (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal Failure [Phase 3]
A Phase 3 population PK study evaluating multiple 10 mg/kg doses of daptomycin (Cubicin) in critically ill patients with bacteremia, endocar…
-
FDA approval · 2016-06-15FDA Approved: DAPTOMYCIN — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved the original application for daptomycin, a bacterial antibiotic, as a generic version manufactured by Hikma Pharmaceuticals USA…
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Evaluation in the Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction With Conventional Blood Culture. [Phase 4]
Phase 4 clinical trial update evaluating PCR testing versus conventional blood culture for nosocomial sepsis, bacteremia, and fungemia.
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: Dressing: Frequency of Change and Evaluation of an Antiseptic-Impregnated Catheter Dressing in ICU Patients [Phase 4]
This Phase 4 trial evaluates how often an antiseptic-impregnated catheter dressing should be changed and assesses its use in ICU patients wi…
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: Virulence Determinants in S Aureus Bacteremia
A Duke University–sponsored trial investigating virulence determinants in Staphylococcus aureus bacteremia has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: Hub Cleansing to Prevent Hub Infection [NA]
A completed clinical trial evaluating hub cleansing to prevent catheter hub infections, with results posted in 2016, in patients with bacter…
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds
A completed clinical trial update examining the immune response in patients with chronic wounds infected by Staphylococcus aureus, including…
-
FDA approval · 2016-03-31FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Eugia US LLC)
The FDA approved a generic vancomycin hydrochloride for injection under an original application from Eugia US LLC. This adds a generic IV op…
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures [NA]
Mayo Clinic conducted a clinical trial on rapid identification and susceptibility testing of pathogens from blood cultures. The results were…
-
CLINICAL_TRIALS research · 2016-03-08Clinical Trial Update: Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral Infections
Observational, prospective clinical study evaluating biomarkers as indicators of acute bacterial or viral infections.
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036) [NA]
A completed NIH-supported clinical trial update focusing on optimizing colistin dosing for infections resistant to all other antibiotics.
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: Efficacy and Safety of an Ethanol/Sodium Citrate Locking Solution: A Pilot Study [NA]
This completed pilot clinical trial evaluated the efficacy and safety of an ethanol/sodium citrate locking solution for preventing catheter-…
-
CLINICAL_TRIALS trial_result · 2015-11-23Clinical Trial Update: Community-Onset Bacteremia Due to ESBL Producing E.Coli or K.Pneumoniae in China: Prevalence, Risk Factors and Prognosis
A completed clinical trial conducted in China examines how common ESBL-producing E. coli and Klebsiella pneumoniae bacteremia is, along with…